Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)

NCT06795204 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia; Adverse Effect
Cardiac Arrhythmia

Interventions

DRUG: HSK3486
DRUG: Moxifloxacin Hydrochloride
DRUG: Placebo

Sponsor

Haisco-USA Pharmaceuticals, Inc.